Categories AlphaGraphs, Earnings, LATEST, Other Industries

Abbott posts strong Q3 results, narrows full year outlook

Pharmaceutical giant Abbott Laboratories (ABT) delivered a 12% increase in third-quarter revenue to $7.7 billion, helped by a 43% increase in diagnostics product sales. The top line surpassed market consensus, which was projected at $7.67 billion.

However, net income from continuing operations fell to $563 million or 31 cents per share, compared to $603 million, or 32 cents per share a year ago. On an adjusted basis, Abbott reported better-than-expected earnings of 75 cents per share, a cent higher than the street expectation.

Abbott Q3 earnings
image courtesy: Open Grid Scheduler

“We achieved another quarter of strong growth and our new product pipeline continues to be highly productive. In spite of increasing currency headwinds, we’re well-positioned to achieve the upper end of our initial full-year guidance,” CEO Miles D. White said in a statement.

The Illinois-based company, meanwhile, narrowed its full-year earnings outlook range on a GAAP basis to $1.33 to $1.35 per share, primarily due to headwinds in the international markets posed by a stronger US dollar.  Excluding one-off items, Abbott expects to earn $2.87 to $2.89 per share.

During the third quarter, sale of Diagnostics products saw the biggest jump of 42.6% to 1.8% billion. The biggest segment, Medical Devices, witnessed a modest 8% growth while the sale of Nutrition products grew 4% during the third quarter.

Abbott posts 17% sales growth for Q2; beats estimates

Abbott shares were down about 2% during pre-market trading on Wednesday.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips. 

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive Company’s Q4 2022 financial results

Colgate-Palmolive Company (NYSE: CL) reported fourth quarter 2022 earnings results today. Net sales increased 5% year-over-year to $4.62 billion. Organic sales growth was 8.5%. Net income attributable to Colgate-Palmolive Company was

Key highlights from Chevron Corporation’s (CVX) Q4 2022 earnings results

Chevron Corporation (NYSE: CVX) reported fourth quarter 2022 earnings results today. Total revenues and other income were $56.4 billion compared to $48.1 billion in the year-ago period. Net income attributable

AXP Earnings: All you need to know about American Express’ Q4 2022 earnings results

American Express Company (NYSE: AXP) reported fourth quarter 2022 earnings results. Consolidated total revenues net of interest expense were $14.2 billion, up 17% from a year ago. Net income was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top